Antiamnesic action of cromakalim, a potassium channel opener, in mice treated with hypoxia- and cerebral ischemia-type stress stimuli
- PMID: 9619298
- PMCID: PMC11560218
- DOI: 10.1023/a:1022553616572
Antiamnesic action of cromakalim, a potassium channel opener, in mice treated with hypoxia- and cerebral ischemia-type stress stimuli
Abstract
1. The amnesia induced by various stress stimuli through hypoxia and cerebral ischemia was evaluated by the shortening of the response latency in a step-through task in mice. 2. The hypoxia-induced amnesia was reduced by cromakalim, a K+ channel opener (KCO), given 10 min before or immediately after the hypoxic treatment. 3. Similarly, the ischemia-induced amnesia was also reduced by cromakalim given 30 min before the occlusion. 4. In ischemic-induced amnesic mice, pyknotic cells, indicating the condensation of chromatin, were observed histochemically at the dentate gyrus granule cells in hippocampal regions 96 hr after ischemic treatment. In addition, cromakalim inhibited the induction of pyknotic cells. 5. These results suggest that KCOs might produce prophylactically neuroprotective effects against hypoxia- and cerebral ischemia-induced amnesia.
Similar articles
-
Influence of potassium channel modulators on cognitive processes in mice.Br J Pharmacol. 1998 Mar;123(6):1079-84. doi: 10.1038/sj.bjp.0701709. Br J Pharmacol. 1998. PMID: 9559889 Free PMC article.
-
Opening of ATP-sensitive potassium channels by cromakalim confers tolerance against chemical ischemia in rat neuronal cultures.Neurosci Lett. 1998 Jul 3;250(2):111-4. doi: 10.1016/s0304-3940(98)00458-3. Neurosci Lett. 1998. PMID: 9697931
-
Preventive effect of cholecystokinin octapeptide on experimental amnesia in rats.Peptides. 1986 Jan-Feb;7(1):105-10. doi: 10.1016/0196-9781(86)90069-0. Peptides. 1986. PMID: 3714527
-
Potassium channel opening drugs and the airways.Braz J Med Biol Res. 1992;25(10):983-98. Braz J Med Biol Res. 1992. PMID: 1342832 Review.
-
Recent developments in the chemistry of potassium channel activators: the cromakalim analogs.Curr Med Chem. 2004 May;11(9):1213-22. doi: 10.2174/0929867043365378. Curr Med Chem. 2004. PMID: 15134515 Review.
Cited by
-
NMDA receptor agonists reverse impaired psychomotor and cognitive functions associated with hippocampal Hbegf-deficiency in mice.Mol Brain. 2015 Dec 4;8(1):83. doi: 10.1186/s13041-015-0176-0. Mol Brain. 2015. PMID: 26637193 Free PMC article.
References
-
- Ankarcrona, M., Dypbukt, J. M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S. A., and Nicotera, P. (1995). Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function. Neuron15:961–973. - PubMed
-
- Carpenter, G. A., and Grossberg, S. (1993). Normal and amnesic learning, recognition and memory by neural model of cortico-hippocampal interactions. Trends Neurosci.16:131–137. - PubMed
-
- Edward, G., and Weston, A. H. (1993). The pharmacology of ATP-sensitive potassium channel. Annu. Rev. Pharmacol. Toxicol.33:597–693. - PubMed
-
- Escande, D., and Cavero, I. (1992). K+ channel openers and “natural” cardioprotection. Trends Pharmacol. Sci.13:269–272. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources